Podcast: The Bargain That Fuels Big Pharma
Kevin Outterson is interviewed.
July 15, 2024 Kellogg InsightA New Drug-Resistant Fungus Is Spreading in Hospitals. Is It The Last of Us in Real Life?
Kevin Outterson is quoted.
March 28, 2023 The BrinkCARB-X Announces Appointment of Dan Burgess as Board Chair
Kevin Outterson is quoted.
March 15, 2023 Medical Plastics NewsPeptilogics Slated to Present Data Regarding Treatment for Joint Replacement Surgery Complications at IDWeek 2021
CARB-X is featured.
Vaxcyte Announces Expanded CARB-X Award to Advance Development of VAX-A1, a Vaccine to Prevent Group A Streptococcus Infections
CARB-X is featured.
CARB-X Celebrates Fifth Anniversary, $361M Invested into Innovative Therapeutics
Kevin Outterson is quoted.
August 3, 2021 Homeland Preparedness NewsThe Next Pandemic is Already Here. Covid Can Teach Us How to Fight It.
Kevin Outterson is quoted.
June 23, 2021 MIT Technology ReviewStriving to Bolster the Antibiotic Pipeline Before it Becomes the Next Crisis
CARB-X is mentioned.
Basilea Awarded CARB-X Grant of Up To USD 2.7 Million to Develop Novel-Class Antibiotic
CARB-X is featured.
Summit Therapeutics Announces Preclinical Candidate and Associated CARB-X Funding Support for the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae, a CDC Urgent Threat and WHO Critical Priority
CARB-X is feautred.